Immunoglobulin Classes

One blueprint, five variations

Every immunoglobulin is built from the same modular kit. The basic unit is a four-chain monomer shaped like the letter Y: two identical heavy chains (about 50 kDa each) and two identical light chains (about 25 kDa each), held together by disulfide bonds. Each chain has a variable region at the tip, where the sequence differs from antibody to antibody and forms the antigen-binding pocket, and a constant region that does not vary within a class. The two arms of the Y are the Fab (fragment antigen-binding) regions; the stem is the Fc (fragment crystallizable) region, which talks to the rest of the immune system — complement, phagocyte Fc receptors, mast cells, and the placental transport machinery.

What makes an immunoglobulin an IgG versus an IgM is its heavy chain. There are five heavy-chain types, each given a Greek letter, and the class is named to match: gamma (γ) → IgG, mu (μ) → IgM, alpha (α) → IgA, epsilon (ε) → IgE, and delta (δ) → IgD. The light chains come in only two flavors, kappa (κ) and lambda (λ), and any class can use either — in humans roughly 60% of antibodies use κ. So the heavy-chain constant region is the single feature that defines the class, and it sets the antibody's hinge flexibility, its ability to polymerize, its half-life, and which effector functions it can trigger.

IgG — the monomeric workhorse

IgG is the most abundant antibody in blood, making up roughly 75% of serum immunoglobulin at a normal concentration of about 8–16 g/L. It circulates as a single Y-shaped monomer, small enough (about 150 kDa) to diffuse out of the bloodstream into tissues and to be the antibody of the secondary (memory) response — the class that floods back when you re-encounter a pathogen you have met before or been vaccinated against. IgG is a generalist: it neutralizes toxins and viruses, opsonizes microbes by coating them so phagocytes can grab their Fc tails, activates the classical complement pathway (though less potently than IgM), and arms natural killer cells for antibody-dependent cellular cytotoxicity.

Humans make four IgG subclasses — IgG1, IgG2, IgG3, and IgG4 — numbered by their serum abundance. IgG1 and IgG3 are strong complement activators and the main responders to protein antigens; IgG2 handles polysaccharide antigens (relevant to encapsulated bacteria like pneumococcus); and IgG4 is unusual in that it does not activate complement well and can swap half-molecules with other IgG4 antibodies, a quirk now central to a family of IgG4-related diseases. IgG also has the longest half-life of any class — about 21 days — because it is rescued from degradation by the neonatal Fc receptor (FcRn), which recycles internalized IgG back to the cell surface. That same receptor ferries maternal IgG across the placenta, giving newborns passive immunity that lasts roughly 6 months.

IgM — the first responder

IgM is the first antibody a B cell makes when it meets a new antigen, appearing within a few days of infection — which is why a positive IgM titer signals a recent or active infection while IgG signals a past or established one. Secreted IgM assembles into a pentamer: five Y-units joined by a small J (joining) chain, giving a giant molecule of about 970 kDa with up to ten antigen-binding sites. That high valency makes IgM superb at agglutinating pathogens and at activating complement — a single bound IgM can fix the first complement component C1q far more efficiently than IgG, because complement needs two adjacent Fc regions and the pentamer supplies them in one molecule.

The trade-off is mobility: IgM is too large to leave the bloodstream easily, so it works mainly intravascularly. The naturally occurring anti-A and anti-B antibodies of the ABO blood group system are IgM, which is why ABO-incompatible transfusions cause immediate, complement-mediated intravascular hemolysis. Before any class switching occurs, IgM is also expressed on the B-cell surface as the antigen receptor (together with IgD). In the lab, IgM's pentameric size is exploited to separate it from IgG by physical methods, and its short-lived nature underpins the classic serologic rule of thumb: IgM means now, IgG means before.

IgA — the mucosal guardian

IgA is the antibody of mucosal surfaces — the gut, respiratory tract, tears, saliva, and breast milk — and the body produces more of it than all other classes combined, on the order of 3–5 grams per day. In serum it travels mostly as a monomer (IgA1 predominates), but at mucosal surfaces it is secreted as a dimer: two monomers linked by a J chain. As the dimer is transported across the epithelial lining by the polymeric immunoglobulin receptor, it picks up a fragment of that receptor called the secretory component, which protects the molecule from being digested by the proteases that fill the gut and airway. The resulting secretory IgA is built to survive a hostile environment.

IgA works mostly by immune exclusion: it binds and neutralizes pathogens and toxins in the mucus layer without triggering inflammation, keeping them from ever reaching the epithelium. This non-inflammatory style is essential at surfaces that must tolerate trillions of commensal microbes. Maternal secretory IgA in breast milk coats the infant gut and is a major reason breastfed babies have fewer enteric infections. When IgA fails, the consequences map to mucosa: selective IgA deficiency is the most common primary immunodeficiency (about 1 in 600 people of European descent), often silent but sometimes causing recurrent sinopulmonary and GI infections, and notably a risk of anaphylaxis to blood products containing IgA. At the other extreme, IgA deposited in the kidney's mesangium causes IgA nephropathy, the world's most common primary glomerulonephritis.

IgE — allergy and antiparasite defense

IgE is present in serum at the lowest concentration of any class — often under 100 IU/mL (roughly 0.0003 g/L) in non-allergic adults — yet it has outsized clinical impact. It is a monomer that spends little time free in the blood because it binds tightly to the high-affinity receptor FcεRI on mast cells and basophils, sitting there like a primed trigger. When allergen cross-links two adjacent IgE molecules on a mast cell, the cell degranulates, releasing histamine, leukotrienes, and other mediators within seconds — the basis of allergic rhinitis, allergic asthma, urticaria, and at its most dangerous, anaphylaxis.

IgE did not evolve to torment hay-fever sufferers; its original job is defense against multicellular parasites, especially helminth worms, which it coats so that eosinophils can attack them in antibody-dependent cellular cytotoxicity. Total and allergen-specific IgE testing guides allergy diagnosis, and very high levels point toward atopic disease, parasitic infection, allergic bronchopulmonary aspergillosis, or the rare hyper-IgE (Job) syndrome. Therapeutically, the monoclonal antibody omalizumab binds free IgE and lowers it, treating severe allergic asthma and chronic spontaneous urticaria — a direct demonstration of how much disease one trace-level antibody class can drive.

IgD — the enigmatic sentinel

IgD is the least understood class. Most of it is membrane-bound, co-expressed with IgM on the surface of mature naive B cells, where the two together form the B-cell antigen receptor and help set the cell's activation threshold. Only a tiny fraction (about 0.25% of serum immunoglobulin) is secreted, and that pool appears to contribute to immune surveillance at the upper respiratory mucosa, where secreted IgD can arm basophils and mast cells. Loss of surface IgD has subtle effects, which is why its role remained murky for decades. It rounds out the family of five and is included here for completeness — but the four functional heavyweights of clinical medicine are IgG, IgM, IgA, and IgE.

How one B cell changes class

A single B cell is not locked into one isotype. Through class switch recombination, a B cell can change its heavy-chain constant region — say from IgM to IgG, IgA, or IgE — while keeping the exact same variable region, so the antibody's antigen specificity is preserved but its effector toolkit is upgraded. The enzyme activation-induced cytidine deaminase (AID) introduces DNA breaks at repetitive switch regions upstream of the constant-region genes; the intervening DNA loops out and is deleted, splicing a new downstream constant gene to the existing variable exon. Helper T-cell cytokines steer the choice: IL-4 pushes toward IgE (and IgG4), TGF-β and IL-21 toward IgA, and interferon-γ toward complement-fixing IgG subclasses. This is why a maturing immune response shifts from early IgM to durable, tailored IgG and IgA.

IgG vs IgM at a glance

The two classes most often compared in clinical serology are IgG and IgM, because together they tell you the timeline and the mechanism of an immune response.

Feature	IgG	IgM
Heavy chain	Gamma (γ)	Mu (μ)
Structure	Monomer (~150 kDa)	Pentamer + J chain (~970 kDa)
Antigen-binding sites	2	10 (up to)
Share of serum Ig	~75%	~10%
Timing of response	Later, sustained for years	First (days), short-lived
Location	Blood and tissues	Mostly intravascular
Complement activation	Moderate (IgG1, IgG3)	Very strong
Crosses placenta	Yes (via FcRn)	No
Half-life	~21 days	~5 days
Clinical signal	Past infection / immunity	Recent / active infection

Why the classes matter clinically

• Serology and diagnosis. IgM-versus-IgG titers date an infection: IgM positive with IgG negative suggests acute disease; both positive suggests recent infection; IgG alone suggests past exposure or vaccination.
• Transfusion medicine. ABO antibodies are IgM and cause immediate intravascular hemolysis, while Rh antibodies are IgG, can cross the placenta, and cause hemolytic disease of the newborn.
• Allergy and asthma. Allergen-specific IgE drives mast-cell degranulation; anti-IgE therapy (omalizumab) treats severe allergic disease.
• Immunodeficiency. Selective IgA deficiency is the most common primary immunodeficiency; low IgG (hypogammaglobulinemia) predisposes to recurrent bacterial infection and is treated with IgG replacement.
• Autoimmunity and kidney disease. IgA nephropathy and IgG4-related disease are defined by the deposition or behavior of a specific class.
• Vaccines. The goal of most vaccines is durable, high-affinity, class-switched IgG — which is why booster doses drive the IgM-to-IgG transition and affinity maturation.

Common misconceptions

• "All antibodies are Y-shaped monomers." Only IgG, IgE, IgD, and serum IgA are monomers; secreted IgA is a dimer and secreted IgM is a pentamer.
• "The variable region defines the class." No — the heavy-chain constant region defines the class; the variable region defines antigen specificity and can stay the same across a class switch.
• "IgM is better than IgG because it has ten binding sites." IgM is a powerful early agglutinator and complement fixer, but it can't leave the blood or cross the placenta, and it fades fast; durable immunity is an IgG job.
• "High IgE always means allergy." Parasitic infection, ABPA, and hyper-IgE syndrome also raise IgE; allergy is the most common but not the only cause.
• "IgA only matters in the gut." It guards every mucosal surface — airways, eyes, breast milk — and its dysfunction shows up as both deficiency syndromes and IgA nephropathy.

This article is educational and is not medical advice. For diagnosis or treatment, consult a qualified clinician.